Haley Perlow, MD
- Assistant Professor, CWRU School of Medicine
- Specialty: Radiation Oncology
- Call: 216-286-3900
Biography: Haley Perlow, MD
Expertise
Certifications & Memberships
- Radiation Oncology - American Board of Radiology
Education
Residency | Radiation Oncology
Radiation Oncology - The Ohio State University Wexner Medical Center (2020 - 2024)
Internship | Transitional Year
Transitional Year - Jackson Memorial Hospital/Jackson Health System (2019 - 2020)
Medical Education
University Of Miami Miller School Of Medicine (2019)
Undergraduate
University Of Arkansas (2015)
About
Haley Perlow, MD, is a board-certified radiation oncologist who specializes in the management of brain and spine tumors. He obtained his medical degree from the University of Miami Miller School of Medicine (Miami, Florida) and completed a radiation oncology residency at Ohio State University, where he served as Chief Resident.
While he was at Ohio State University, he specialized in clinical trial development and served as the principal investigator on a clinical trial evaluating interventions to improve cognition for patients with brain metastases. He received further training through invitation to the AACR/ASCO Workshop on Methods in Clinical Cancer Research. He received many national awards in recognition of his research accomplishments during his time at Ohio State University and has been awarded multiple grants to support his research efforts.
Dr. Perlow has authored many articles for many peer-reviewed journals, including Nature Medicine; JAMA Oncology; Neuro-Oncology; International Journal of Radiation Oncology, Biology, Physics; Journal of Neuro-Oncology; and Neurosurgery. He has been invited to deliver oral presentations at national meetings and conferences held by the American Society for Therapeutic Radiology and Oncology (ASTRO), Society for Neuro-Oncology (SNO), American Society of Clinical Oncology (ASCO) and American Radium Society (ARS), among others. Dr. Perlow has been an invited speaker at many regional and national meetings and conferences. He serves as a peer reviewer for a number of journals, including Neuro-Oncology; International Journal of Radiation Oncology, Biology, Physics; and Journal of Neuro-Oncology .
Among other awards and honors, Dr. Perlow is the recipient of the ASTRO Resident Clinical/Basic Science Research Abstract Award (2021), ASTRO Annual Meeting Abstract Recognition Award (2022), ARS Annual Meeting Travel Grant (2022) and the ASTRO Basic/Translational Science Award (2025). Professional societies in which he is a member include the American Society of Clinical Oncology (ASCO), American Board of Radiology (ABR), Society for Neuro-Oncology (SNO) and American Society of Therapeutic Radiation Oncology (ASTRO).
Dr. Perlow’s number one priority is delivering the best possible care to his patients. His current research interests include clinical trial development and implementation, protecting neurocognition and quality of life for brain tumor patients, leveraging advanced imaging to design radiotherapy treatments, and expanding indications for radiotherapy to treat functional disorders.
Research & Publications
Research Links
PubMed
View Research
Research Interests
Clinical trials, primary brain tumors, brain metastases, spine tumors, neurocognition, quality of life, advanced imaging, functional radiosurgery
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Haley Perlow did not disclose any Outside Relationships with Industry.